Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kate Smith

Showing results (141-150 of 177) with videos related to

Pageof 18
Sort By:
European Geriatric Medicine|September 16, 2025
Physical activity interventions for hospitalised people living with dementia: systematic review and meta-analysisEmma Elliott, Jodi Ventre, Sarah Kate Smith, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 7, 2003
HIV-1 protease and reverse transcriptase mutation patterns responsible for discordances between genotypic drug resistance interpretation algorithmsJaideep Ravela, Bradley J Betts, Francoise Brun-Vézinet, et al.
Internal Medicine Journal|December 30, 2023
Medications and cognitive risk in Aboriginal primary care: a cross-sectional studyMarycarol Holdaway, Zoë Hyde, Jo-Anne Hughson, et al.
Transplantation|November 22, 2022
Assessing the Impact of Prophylactic Eculizumab on Renal Graft Survival in Atypical Hemolytic Uremic SyndromeEmily K Glover, Kate Smith-Jackson, Vicky Brocklebank, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|October 26, 2025
Adaptation of the Good Spirit, Good Life quality of life tool for remote Indigenous AustraliansLianne Gilchrist, Leon Flicker, Dawn Bessarab, et al.
British Journal of Clinical Pharmacology|November 26, 2002
Pharmacokinetic and pharmacodynamic profile following oral administration of the phosphodiesterase (PDE)4 inhibitor V11294A in healthy volunteersDonna Donigi Gale, Linda J Landells, Domenico Spina, et al.
BJUI Compass|November 14, 2024
Treatment preferences of patients with muscle invasive bladder cancer: A discrete choice experimentLiam Mannion, Verity Watson, Vinod Mullassery, et al.
Kidney International|January 23, 2025
The membrane attack complex drives thrombotic microangiopathy in complement mediated atypical hemolytic uremic syndromeKate Smith-Jackson, Patrick Walsh, Wioleta M Zelek, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 18, 2023
Co-design of dementia prevention program for Aboriginal Australians (DAMPAA)Irene Mateo-Arriero, Alexander Lalovic, Glennette Dowden, et al.
Haematologica|September 29, 2022
Plasminogen activator-coated nanobubbles targeting cellbound β2-glycoprotein I as a novel thrombus-specific thrombolytic strategyPaolo Macor, Paolo Durigutto, Monica Argenziano, et al.
Pageof 18

Showing results (141-150 of 177) with videos related to

Sort By:
Pageof 18
European Geriatric Medicine|September 16, 2025
Physical activity interventions for hospitalised people living with dementia: systematic review and meta-analysisEmma Elliott, Jodi Ventre, Sarah Kate Smith, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 7, 2003
HIV-1 protease and reverse transcriptase mutation patterns responsible for discordances between genotypic drug resistance interpretation algorithmsJaideep Ravela, Bradley J Betts, Francoise Brun-Vézinet, et al.
Internal Medicine Journal|December 30, 2023
Medications and cognitive risk in Aboriginal primary care: a cross-sectional studyMarycarol Holdaway, Zoë Hyde, Jo-Anne Hughson, et al.
Transplantation|November 22, 2022
Assessing the Impact of Prophylactic Eculizumab on Renal Graft Survival in Atypical Hemolytic Uremic SyndromeEmily K Glover, Kate Smith-Jackson, Vicky Brocklebank, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|October 26, 2025
Adaptation of the Good Spirit, Good Life quality of life tool for remote Indigenous AustraliansLianne Gilchrist, Leon Flicker, Dawn Bessarab, et al.
British Journal of Clinical Pharmacology|November 26, 2002
Pharmacokinetic and pharmacodynamic profile following oral administration of the phosphodiesterase (PDE)4 inhibitor V11294A in healthy volunteersDonna Donigi Gale, Linda J Landells, Domenico Spina, et al.
BJUI Compass|November 14, 2024
Treatment preferences of patients with muscle invasive bladder cancer: A discrete choice experimentLiam Mannion, Verity Watson, Vinod Mullassery, et al.
Kidney International|January 23, 2025
The membrane attack complex drives thrombotic microangiopathy in complement mediated atypical hemolytic uremic syndromeKate Smith-Jackson, Patrick Walsh, Wioleta M Zelek, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 18, 2023
Co-design of dementia prevention program for Aboriginal Australians (DAMPAA)Irene Mateo-Arriero, Alexander Lalovic, Glennette Dowden, et al.
Haematologica|September 29, 2022
Plasminogen activator-coated nanobubbles targeting cellbound β2-glycoprotein I as a novel thrombus-specific thrombolytic strategyPaolo Macor, Paolo Durigutto, Monica Argenziano, et al.
Pageof 18